Skip to main content
. 2022 May 4;103(4):115721. doi: 10.1016/j.diagmicrobio.2022.115721

Table 3.

Sensitivity and specificity of procalcitonin for co-infections in COVID-19 patients.

>0.25 ng/mL >0.5 ng/mL 1 ng/mL
Sensitivity 82% 58% 44%
Specificity 47% 61% 71%
Positive Predictive Value 13% 13% 13%
Negative Predictive Value 96% 94% 93%